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ABSTRACT 
The prevalence of skin infection is on the rise globally affecting millions of people. Skin infection, which was once given low priority now has better 
acknowledgment due to the serious impact it has on people’s quality of life. The misuse or inappropriate use of antimicrobials to treat the skin infection 
has eventually led to the growth of emerging and spreading of microorganism. Besides that, the lack of awareness of the public on skin infection and its 
associated risk factors further enhances the spreading and worsening of skin infection affecting the quality of life of themselves and people around. 
Thus, the pharmacists play an important role to create the awareness on the appropriate use of antimicrobials for skin infection treatment among 
healthcare professionals as well as to educate the public on the skin infection and its risk factors for better management of skin infection.  
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (
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Skin infection can be defined as the invasion and multiplication of 
microorganism such as bacteria, fungal, viral or parasites on the 
skin, which are usually absent within the body [1]. Skin infection can 
be classified into primary infection and secondary infection. Primary 
infections are usually caused by a single pathogen which usually 
enters through a break on a normal, healthy skin, and this type of 
infection will have a characteristic morphology and disease course. 
For example, Staphylococcus aureus, B-hemolytic streptococci, and 
coryneform bacteria are some of the most common pathogens 
causing primary infections. Whereas secondary infections appears 
as a superimposed condition of an already diseased skin. Hence, the 
clinical picture and disease course varies due to the underlying 
disease. The most common pathogens leading to secondary infection 
are Pseudomonas aeruginosa and gram-negative rods such as 
Escherichia coli, Haemopihilus influenza, Clostridium species, 
Mycobacterium species and Pseudomonas species [2]. Skin infections 
are mainly treated with antimicrobials such as antibiotics, 
antifungal, antivirals, and antiparasitic [3]. 
INTRODUCTION 
Skin conditions are a major cause for consultation in the primary 
care with up to 2% of consultations in general practice worldwide 
accounting to dermatological conditions [4]. In the Fourth National 
Morbidity Survey in England and Wales estimated about 10million 
consultations in general practice were due to skin conditions of 
which 2.4million were initiated due to infection [5]. Nevertheless, a 
study done by MA Brujinzeels et al. and the Weekly Returns Service 
(WRS) of the Royal College of General Practitioners (RCGP) reported 
that doctors were only consulted on a minority of occasions with 
only 28% of all skin problems consulting the general practitioner [6] 
while another study also reports that up to 80% of the population 
suffering with skin problems do not seek medical help [7]. However, 
nowadays community pharmacists have become the first-line 
healthcare professionals for consultations [8, 9]. This has been 
proven by studies which state that pharmacists play an important 
role in dermatological problems over the decade [10, 1]. This is 
because topical antimicrobials are now available as over-the-counter 
(OTC) medications for treatment of common skin infections. 
However, the treatment of skin infection relies on three phases for a 
rational use of the drug. The first and most crucial phase is the 
appropriate diagnosis, which is merely based on physician’s clinical 
experience and diagnostic tests. The second crucial phase of 
treatment is the rational prescribing which is based on the 
physician’s knowledge on the pathophysiology of the disease, 
knowledge on the risks and benefits of drug prescribed. The next 
crucial treatment phase is the appropriate use and adherence of 
patients to drugs as prescribed by the prescriber. Drugs are needed 
to be used rationally as irrational or non-specific drug use may 
produce harmful or beneficial effects. Furthermore, in developing 
countries, irrational use of drugs was found to cause a shortage of 
drug resources and an increase in expenditure and burden to treat 
the adverse clinical effect of the drug [12]. This is mainly due to the 
rising of antimicrobial resistance all over the world as new 
resistance mechanism is emerging and spreading globally [13]. 
Hence, the goal of treatment in dermatological practice is to achieve 
the best possible outcome in the shortest period with the least 
number of safe drugs at a reasonable cost to patients. This, however, 
can be achieved by monitoring, evaluating and therapeutically 
analyzing the prescribing patterns of drugs for skin condition [14]. 
Level of awareness of skin infection 
Skin infection can be caused by many factors, but nevertheless, the 
lack of awareness remains the main factor. Good knowledge of skin 
infection will increase the awareness level so that the skin infection 
can be treated accordingly as well as avoid the risk factors leading to 
skin infection for a better QoL. A study was done by Goonmatee K. et. 
al revealed that the majority of the study carried out were from 
middle household income and had tertiary education, had good 
knowledge and were aware of skin infection. Hence, the respondents 
who were knowledgeable in skin infection practiced good hygiene 
and were aware of risk factors causing skin infection. For instance, 
73% of respondents knew to use and sharing cosmetics was a risk 
factor while 78% respondents were aware that the sharing of 
personal belonging was a risk factor of skin infection [15]. This has 
been further proven by a study which shows that acne patients who 
were emotionally more affected were more likely to adhere to 
treatment as they are more aware of the condition which leads to a 
better outcome and improved quality of life QoL) [16]. Besides that, 
psoriasis patients also prove that insufficient knowledge can cause 
the patient to undermine their decision making in daily life affecting 
their QoL [17]. The level of awareness can be improved by providing 
the public with proper health education and healthcare system 
which eventually highlights the significance of firm awareness of 
health information. 
Prescribing pattern of drug 
There is a lack of studies on the prescribing patterns of 
antimicrobials by the pharmacist for skin infections in the 
community pharmacy settings. However, worldwide, there are many 
studies which were carried out on prescribing patterns of drugs 
prescribed by general practitioners. The data collected from these 
studies were then used to constitute guidelines to improve drug 
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utilization, modify the prescription of drugs for better therapeutic 
outcome and decreased adverse effect [12], identify polypharmacy 
and drug-drug interaction, implement economic aspects in the chain 
of drug use [14], assist in providing rational and cost-effective 
medical care [18,9] and finally implement standards of medical 
treatment in the healthcare system [12]. Nevertheless, over the 
recent decade, antimicrobial resistance is still on the rise in many 
countries, despite the efforts to control it. The inappropriate or 
misuse of the antimicrobials is the main reason for the development 
of resistance pathogens and the emergence of superbugs [13, 9]. 
Nevertheless, the antimicrobial resistance development can be 
narrowed down to the overuse of antibiotics leading to the selection 
of resistant bacteria in the commensal selection [20-2]. In the 
Europe, studies found that over 90% of all antibiotics for human use 
are prescribed in the primary health care [21, 3]. Inappropriate 
treatment with antibiotics will lead to the limited effectiveness to 
the patient, causes the unnecessary cost to the health care system 
and finally further increases the antimicrobial incidence [24-6]. 
Besides, a study by Bronzwear et al. shows resistance to be more 
prevalent in countries where antibiotic is used at a particularly high 
rate [27]. Thus, the appropriate use of antibiotics is important to 
limit the emergence of the resistant organism [28]. WHO also added 
that the health workers and pharmacist can help prevent resistance 
by only prescribing and dispensing the right antibiotics to patients 
only when they are truly needed [13]. Several studies have also 
advocated cautious and appropriate prescribing of antibiotics to 
control the antimicrobial emergence [24, 9]. This can be carried out 
providing empirical treatment with antibiotics only if necessary and 
should ideally also include appropriate agents which are effective 
against most common pathogenic agents [29]. 
Rising risk factors of Skin Infection 
Besides the misuse and inappropriate use of drugs, poor infection 
prevention and control practices also contributes to further 
emergence and spread of microorganism [13] lead to worsening of 
skin infection. This is mainly due to the lack of awareness of the 
public about risk factors causing skin infection. For instance, the 
public has yet to realize that sharing of cosmetic between women 
and sharing of belongings such as toothbrush, towel, razors, soaps, 
and combs is one of the main risk factors of skin infection [30,1]. 
This has been proven by studies which shows that lip cosmetics 
could spread contagious herpes simplex virus causing cold sores on 
lips [30]. Besides that, tattoo and piercing have become a worldwide 
mainstream fashion among adults in the last 10-20years leading to 
the rise of skin infection [32]. According to a review by Barn P et. al, 
1 case-control study, 1 outbreak investigation, 3 reviews and 24 case 
reports were reported on skin infection due to piercing caused 
mainly by bacteria, such as Pseudomonas, Streptococcus and 
Mycobacterium and another 2 studies reporting on viral infection 
[33]. Fisher et al. and Keener et al. also reported cartilage piercing 
posted a higher skin infection risk compared to earlobe piercing 
[34,5]. While studies by Kay et al., shows that tattoo has caused 
outbreaks of M. Haemophillium in two males in Washington State 
[36] while Drage et al. reported 6 individuals infected with M. 
Chelonae in the United States due to the use of municipal water for 
tattooing [37]. The second outbreak was reported by Goldman et al. 
in France when two tattooists were implicated with 48 patients 
suffered from a skin infection around the tattooed area with cultures 
from open tattoo ink bottle being positive for M. Chelonae [38]. 
Moreover, several case reports reported 4 mycobacterial 
infection case and 2 Pseudomonas aeruginosa and Streptococcus 
pyrogens cases [33]. Furthermore, sweating is also another risk 
factor of infection usually neglected by many. Wearing tight and 
non-cotton clothes can cause sweating which eventually leads to 
the increased risk of skin infection. This has been proven by a 
new study which shows that people with hyperhidrosis, which is 
excessive sweating are more prone to skin infection caused by 
bacteria, fungi and viruses [39]. Thus, it is important to educate 
the patients on the risk factors causing skin infection to create 
awareness so that the risk factor can be avoided or reduced in 
order for a better QoL.  
The role of pharmacist and antimicrobial stewardship 
programs 
The antimicrobial stewardship program is used to improve patient 
outcomes while minimizing unintended consequences of 
antimicrobial use in the practice settings of health systems. The 
American Society of Health-System Pharmacists (ASHP) believes 
that pharmacist plays an important role in antimicrobial 
stewardship program and also takes part in the infection prevention 
and control programs on the health system. The responsibilities of 
the pharmacist in this system are to promote the optimal 
antimicrobial use, hence, reducing the infection transmission as well 
as educating the patients, health professionals, and the public. 
Besides that, they should participate in all efforts to prevent and 
reduce infection transmission among the patients and health care 
systems [40]. The pharmacist can take part in educational activities 
to educate the health professionals, patients and the public on the 
antimicrobial use as well as provide knowledge on the risk factors of 
skin infection to bring awareness among them to reduce the 
occurrence and spreading of skin infection for a better QoL [41]. 
This can be done by providing clinical conferences, newsletters or 
educational forum for health professionals on antimicrobials and 
resistance. Besides that, pharmacists can educate and counsel 
patients about the adherence to prescribed antimicrobial 
medications and the prevention and control of infection. 
Furthermore, public health education and awareness programs 
should be carried out aimed to controlling the incidence and 
spreading on infection [40].  
CONCLUSION 
Skin infection rises globally as the emergence of microorganism 
throughout the world increases mainly due to the lack of awareness 
of the public on skin infection and the misuse or inappropriate use of 
antimicrobials to treat skin infections. Hence, many studies have 
been carried out throughout the world to assess the level of 
awareness of the public on skin infection as well as the prescribing 
patterns of antimicrobials for the treatment of skin infection which 
is lacking in Malaysia. Thus, further studies need to be conducted in 
Malaysia so that dermatological educational programs can be 
encouraged among pharmacist to bring awareness on skin infection 
among the public and educate the healthcare settings on the 
appropriate use of antimicrobials.  
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